Loading cancer entity…
Loading cancer entity…
Clinical trials
86 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00744185 | Propranolol in Capillary Hemangiomas(HEMANGIOMA) | terminated | Phase 2 / Phase 3 | 14 | University Hospital, BordeauxOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT02110069 | A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors | terminated | Phase 2 | 4 | Boston Children's HospitalOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT01074437 | Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH) | terminated | Phase 2 | 9 | Seattle Children's HospitalOTHER | 1 | Oct 4, 2018 | clinicaltrials |
| NCT00555464 | Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas | terminated | Phase 2 | 8 | Medical College of WisconsinOTHER | 1 | Jun 11, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Jun 1, 2026source: clinicaltrials